CoChat

Kv7/M channel dysfunction produces hyperexcitability in hippocampal CA1 pyramidal cells of Fmr1 knockout mice

Open access
Luque, M. Angeles, Morcuende, Sara, Torres, Blas, Herrero, Luis · 2024 · The Journal of Physiology

The DOI matches its Crossref record; 90 of the 91 references it cites were found in a registry or an index.

Abstract

Fragile X syndrome (FXS), the most frequent monogenic form of intellectual disability, is caused by transcriptional silencing of the FMR1 gene that could render neuronal hyperexcitability. Here we show that pyramidal cells (PCs) in the dorsal CA1 region of the hippocampus elicited a larger action potential (AP) number in response to suprathreshold stimulation in juvenile Fmr1 knockout (KO) than wild‐type (WT) mice. Because Kv7/M channels modulate CA1 PC excitability in rats, we investigated if their dysfunction produces neuronal hyperexcitability in Fmr1 KO mice. Immunohistochemical and western blot analyses showed no differences in the expression of Kv7.2 and Kv7.3 channel subunits between genotypes; however, the current mediated by Kv7/M channels was reduced in Fmr1 KO mice. In both genotypes, bath application of XE991 (10 μM), a blocker of Kv7/M channels: produced an increased AP number, produced an increased input resistance, produced a decreased AP voltage threshold and shaped AP medium afterhyperpolarization by increasing mean velocities. Retigabine (10 μM), an opener of Kv7/M channels, produced opposite effects to XE991. Both XE991 and retigabine abolished differences in all these parameters found in control conditions between genotypes. Furthermore, a low concentration of retigabine (2.5 μM) normalized CA1 PC excitability of Fmr1 KO mice. Finally, ex vivo seizure‐like events evoked by 4‐aminopyiridine (200 μM) in the dorsal CA1 region were more frequent in Fmr1 KO mice, and were abolished by retigabine (5–10 μM). We conclude that CA1 PCs of Fmr1 KO mice exhibit hyperexcitability, caused by Kv7/M channel dysfunction, and increased epileptiform activity, which were abolished by retigabine. image Key points: Dorsal pyramidal cells of the hippocampal CA1 region of Fmr1 knockout mice exhibit hyperexcitability. Kv7/M channel activity, but not expression, is reduced in pyramidal cells of the hippocampal CA1 region of Fmr1 knockout mice. Kv7/M channel dysfunction causes hyperexcitability in pyramidal cells of the hippocampal CA1 region of Fmr1 knockout mice by increasing input resistance, decreasing AP voltage threshold and shaping medium afterhyperpolarization. A Kv7/M channel opener normalizes neuronal excitability in pyramidal cells of the hippocampal CA1 region of Fmr1 knockout mice. Ex vivo seizure‐like events evoked in the dorsal CA1 region were more frequent in Fmr1 KO mice, and such an epileptiform activity was abolished by a Kv7/M channel opener depending on drug concentration. Kv7/M channels may represent a therapeutic target for treating symptoms associated with hippocampal alterations in fragile X syndrome.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1113/jp285244

Cites

90 of 90 references verified0 citation errors · 0 not checkable

Statistics

Figures

Image 1
CC-BY-NC-ND · From the PDF
Image 2
CC-BY-NC-ND · From the PDF
Figure 1 Pyramidal cells of the CA1 hippocampal region are hyperexcitable in the Fmr1 KO mice A and B , current steps and ramps elicited action potential (AP) repetitive firing in both wildtype (WT) and Fmr1 KO (KO) mice, but AP number was larger in Fmr1 KO mice. C and D , histograms showing AP numbers in response to different intensities of current steps ( C ) or ramp ( D ). Asterisks indicate significant differences (two-way ANOVA test with Bonferroni correction, P < 0.05 in C ; Student's unpaired t test, P < 0.05 in D ). Data bars are shown as means ± SD for WT ( n = 14 cells, N = 10 animals) and Fmr1 KO ( n = 16 cells, N = 12 animals) mice. [Colour figure can be viewed at wileyonlinelibrary.com]
Figure 1 Pyramidal cells of the CA1 hippocampal region are hyperexcitable in the Fmr1 KO mice A and B , current steps and ramps elicited action potential (AP) repetitive firing in both wildtype (WT) and Fmr1 KO (KO) mice, but AP number was larger in Fmr1 KO mice. C and D , histograms showing AP numbers in response to different intensities of current steps ( C ) or ramp ( D ). Asterisks indicate significant differences (two-way ANOVA test with Bonferroni correction, P < 0.05 in C ; Student's unpaired t test, P < 0.05 in D ). Data bars are shown as means ± SD for WT ( n = 14 cells, N = 10 animals) and Fmr1 KO ( n = 16 cells, N = 12 animals) mice. [Colour figure can be viewed at wileyonlinelibrary.com]CC-BY-NC-ND · From the PDF
Figure 2 Kv7/M channel activity, but not expression, is reduced in the hippocampal CA1 pyramidal cells (PC) of Fmr1 KO mice
Figure 2 Kv7/M channel activity, but not expression, is reduced in the hippocampal CA1 pyramidal cells (PC) of Fmr1 KO miceCC-BY-NC-ND · From the PDF
Figure 3 The Kv7/M channel blocker XE991 (10 µ M) and opener retigabine (10 µ M) abolished the difference in AP number found between wildtype (WT) and Fmr1 KO (KO) mice in control conditions A and C , representative recordings of AP repetitive discharge in response to 100 pA current steps in control conditions and during bath application of XE991 ( A ) or retigabine ( C ). B and D , histograms showing AP number in response to different intensities of current steps in control conditions and during bath application of XE991 ( B ) or retigabine ( D ). Asterisks indicate significant differences (Student's unpaired t test, P < 0.05). n.s., not significant. Data bars are shown as means ± SD for WT ( n = 8 cells, N = 6 animals in B ; n = 6 cells, N = 5 animals in D ) and Fmr1 KO ( n = 8 cells, N = 6 animals in B ; n = 8 cells, N = 6 animals in D ) mice. [Colour figure can be viewed at wileyonlinelibrary.com]
Figure 3 The Kv7/M channel blocker XE991 (10 µ M) and opener retigabine (10 µ M) abolished the difference in AP number found between wildtype (WT) and Fmr1 KO (KO) mice in control conditions A and C , representative recordings of AP repetitive discharge in response to 100 pA current steps in control conditions and during bath application of XE991 ( A ) or retigabine ( C ). B and D , histograms showing AP number in response to different intensities of current steps in control conditions and during bath application of XE991 ( B ) or retigabine ( D ). Asterisks indicate significant differences (Student's unpaired t test, P < 0.05). n.s., not significant. Data bars are shown as means ± SD for WT ( n = 8 cells, N = 6 animals in B ; n = 6 cells, N = 5 animals in D ) and Fmr1 KO ( n = 8 cells, N = 6 animals in B ; n = 8 cells, N = 6 animals in D ) mice. [Colour figure can be viewed at wileyonlinelibrary.com]CC-BY-NC-ND · From the PDF
Figure 4 The Kv7/M channel blocker XE991 (10 µ M) and opener retigabine (10 µ M) abolished the difference in input resistance, action potential (AP) voltage threshold and rheobase found between wildtype (WT) and Fmr1 KO (KO) mice in control conditions
Figure 4 The Kv7/M channel blocker XE991 (10 µ M) and opener retigabine (10 µ M) abolished the difference in input resistance, action potential (AP) voltage threshold and rheobase found between wildtype (WT) and Fmr1 KO (KO) mice in control conditionsCC-BY-NC-ND · From the PDF
Figure 5 The Kv7/M channel blocker XE991 (10 µ M) and opener retigabine (10 µ M) shaped action potential (AP) medium afterhyperpolarization (mAHP) during AP repetitive discharge and abolished differences in the AP interspike interval found in control conditions between CA1 pyramidal cells (PCs) of the wildtype (WT) and Fmr1 KO (KO) mice
Figure 5 The Kv7/M channel blocker XE991 (10 µ M) and opener retigabine (10 µ M) shaped action potential (AP) medium afterhyperpolarization (mAHP) during AP repetitive discharge and abolished differences in the AP interspike interval found in control conditions between CA1 pyramidal cells (PCs) of the wildtype (WT) and Fmr1 KO (KO) miceCC-BY-NC-ND · From the PDF
Figure 6 Low concentrations of the Kv7/M channel opener retigabine normalize action potential (AP) firing in the CA1 pyramidal cells (PCs) of Fmr1 KO mice
Figure 6 Low concentrations of the Kv7/M channel opener retigabine normalize action potential (AP) firing in the CA1 pyramidal cells (PCs) of Fmr1 KO miceCC-BY-NC-ND · From the PDF
Figure 7 Epileptiform activity is greater in the dorsal CA1 region of Fmr1 KO than WT mice and is abolished by retigabine in a concentration-dependent manner A , representative field potential recordings obtained in slices from WT and Fmr1 KO mice showing seizure-like events evoked by 4-AP (200 μ M). Retigabine at 2.5 or 5 μ M diminished or abolished ictal activity, respectively. Retigabine washout led to a recovery of epileptiform activity. Recordings were bandpassed (2-2500 Hz) for illustrations. Arrowheads point the ictal events shown at the right of each panel with an expanded time scale. Note, however, the cease of activity caused by retigabine 5 μ M(arrow) as illustrated at an expanded time scale. B ,
Figure 7 Epileptiform activity is greater in the dorsal CA1 region of Fmr1 KO than WT mice and is abolished by retigabine in a concentration-dependent manner A , representative field potential recordings obtained in slices from WT and Fmr1 KO mice showing seizure-like events evoked by 4-AP (200 μ M). Retigabine at 2.5 or 5 μ M diminished or abolished ictal activity, respectively. Retigabine washout led to a recovery of epileptiform activity. Recordings were bandpassed (2-2500 Hz) for illustrations. Arrowheads point the ictal events shown at the right of each panel with an expanded time scale. Note, however, the cease of activity caused by retigabine 5 μ M(arrow) as illustrated at an expanded time scale. B ,CC-BY-NC-ND · From the PDF

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 90 references

Research works printed but not linked: 1

  1. 10.7554/elife.92563.3 · doi:10.7554/elife.92563.3

Cited by

See all 9

Metadata

Authors
Luque, M. A., Morcuende, S., Torres, B., & Herrero, L.
Affiliations
Universidad de Sevilla (ES)
Corresponding author
Herrero, Luis
Venue
The Journal of Physiology
Publisher
Wiley
Published
2024-07-08
Volume
602
Issue
15
Pages
3769-3791
ISSN
  • 0022-3751 (ISSN-L)
  • 1469-7793
OpenAlex
W4400411948
Cited by
9
References
91
Citations by year
2026: 5 · 2025: 4
FWCI
2.39
Type
journal article
Language
en
Open access
Locations
  • The Journal of Physiology (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
Universidad de Sevilla (2022/00000326, 2024/00000601)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
fragile X syndrome, Fmr1 knockout mice, neuronal hyperexcitability, CA1 pyramidal neurons, retigabine, XE991, epileptiform activity, action potential threshold, input resistance, Kv7.2, Kv7.3, intellectual disability, seizure-like events
MeSH terms
Action Potentials, Animals, Anthracenes, Carbamates, Fragile X Syndrome, Male, Mice, Inbred C57BL, Nerve Tissue Proteins, Phenylenediamines, Pyramidal Cells, Mice, Knockout, Mice, KCNQ2 Potassium Channel, KCNQ3 Potassium Channel, Fragile X Messenger Ribonucleoprotein 1, Fragile X Mental Retardation Protein, CA1 Region, Hippocampal

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.